Researchers show multiple sclerosis drug can be used as Alzheimer's therapy

by Lindsay Travis,University of KentuckyWorking model for the effect of ponesimod on microglial activation and phagocytosis. Aβ42 binds to TLR4 and induces a complex with S1PR1. S1P co-activates

Updated on: March 02,2024 13

Researchers show multiple sclerosis drug can be used as Alzheimer's therapy

by Lindsay Travis,University of KentuckyWorking model for the effect of ponesimod on microglial activation and phagocytosis. Aβ42 binds to TLR4 and induces a complex with S1PR1. S1P co-activates

Updated on:March 02,2024 13

Expert offers perspective on experimental Alzheimer's disease drug

by Deb BalzerCredit: Pixabay/CC0 Public DomainAccording to drugmakers Eisai and Biogen, a Phase 3 clinical study on a potential new Alzheimer's disease drug shows promise. The study findings show

Updated on: April 18,2024 0

Expert offers perspective on experimental Alzheimer's disease drug

by Deb BalzerCredit: Pixabay/CC0 Public DomainAccording to drugmakers Eisai and Biogen, a Phase 3 clinical study on a potential new Alzheimer's disease drug shows promise. The study findings show

Updated on:April 18,2024 0

Blood levels of common antiepileptic drugs drop during pregnancy, causing breakthrough seizures

by University of PittsburghCredit: Unsplash/CC0 Public DomainBlood levels of many commonly used antiepileptic drugs drop dramatically with the onset of pregnancy, report researchers from the Univ

Updated on: February 03,2024 16

Blood levels of common antiepileptic drugs drop during pregnancy, causing breakthrough seizures

by University of PittsburghCredit: Unsplash/CC0 Public DomainBlood levels of many commonly used antiepileptic drugs drop dramatically with the onset of pregnancy, report researchers from the Univ

Updated on:February 03,2024 16

Alzheimer's research strengthens evidence for reanalyzing data in clinical trials that 'failed'

by Ellen Goldbaum,University at BuffaloCredit: Unsplash/CC0 Public DomainNew research on Alzheimer's disease led by the University at Buffalo reveals strong evidence that clinical trials on

Updated on: April 16,2024 14

Alzheimer's research strengthens evidence for reanalyzing data in clinical trials that 'failed'

by Ellen Goldbaum,University at BuffaloCredit: Unsplash/CC0 Public DomainNew research on Alzheimer's disease led by the University at Buffalo reveals strong evidence that clinical trials on

Updated on:April 16,2024 14

Recorded deaths from dementia more than double in 13 years

by Gisela Valencia,Alzheimer's Research UKNew figures released today show the proportion of people dying with a diagnosis of dementia more than doubled in 13 years. According to reports publ

Updated on: March 07,2024 10

Recorded deaths from dementia more than double in 13 years

by Gisela Valencia,Alzheimer's Research UKNew figures released today show the proportion of people dying with a diagnosis of dementia more than doubled in 13 years. According to reports publ

Updated on:March 07,2024 10

FDA advisory panelist outlines issues with aducanumab's approval for Alzheimer's disease

by American College of PhysiciansPET scan of a human brain with Alzheimer's disease. Credit: public domainDespite near unanimous objection from its advisory panel, the U.S. Food and Drug Admi

Updated on: March 30,2024 10

FDA advisory panelist outlines issues with aducanumab's approval for Alzheimer's disease

by American College of PhysiciansPET scan of a human brain with Alzheimer's disease. Credit: public domainDespite near unanimous objection from its advisory panel, the U.S. Food and Drug Admi

Updated on:March 30,2024 10

Risk factors for dementia vary by ethnicity, study finds

by Public Library of ScienceModifiable risk factors—including hypertension, obesity, diabetes, low HDL cholesterol and sleep disorders—confer a higher risk of dementia for people in some minority

Updated on: March 02,2024 10

Risk factors for dementia vary by ethnicity, study finds

by Public Library of ScienceModifiable risk factors—including hypertension, obesity, diabetes, low HDL cholesterol and sleep disorders—confer a higher risk of dementia for people in some minority

Updated on:March 02,2024 10

Discovery adds context to Alzheimer's fight

by Paul Mayne,University of Western OntarioRobarts Research Institute scientists Vania and Marco Prado have found a gene, TRPM2, that could be a therapeutic target to assist in decreasing cognit

Updated on: February 27,2024 13

Discovery adds context to Alzheimer's fight

by Paul Mayne,University of Western OntarioRobarts Research Institute scientists Vania and Marco Prado have found a gene, TRPM2, that could be a therapeutic target to assist in decreasing cognit

Updated on:February 27,2024 13

Big data initiative discovers new causal pathways in Alzheimer's

by King's College LondonFlowchart of study design. CTL, cognitively normal controls; MCI, mild cognitive impairment; AD, Alzheimer's disease; Aβ, β-amyloid; CSF, cerebrospinal fluid; A, a

Updated on: May 20,2024 5

Big data initiative discovers new causal pathways in Alzheimer's

by King's College LondonFlowchart of study design. CTL, cognitively normal controls; MCI, mild cognitive impairment; AD, Alzheimer's disease; Aβ, β-amyloid; CSF, cerebrospinal fluid; A, a

Updated on:May 20,2024 5

Brain stimulation shows promise for Alzheimer's disease in early trial

by Alzheimer's Research UKPET scan of a human brain with Alzheimer's disease. Credit: public domainScientists in the US have found that electrically stimulating regions of the brain in th

Updated on: May 13,2024 6

Brain stimulation shows promise for Alzheimer's disease in early trial

by Alzheimer's Research UKPET scan of a human brain with Alzheimer's disease. Credit: public domainScientists in the US have found that electrically stimulating regions of the brain in th

Updated on:May 13,2024 6

From Alzheimer's to autism, nuclear neurology could launch revolution in diagnosing and treating brain diseases

by Ellen Goldbaum,University at BuffaloImage of glucose metabolism PET overlaid on CT in an Alzheimer's patient with mild dementia. Green arrow points to regional hypometabolism in the media

Updated on: May 13,2024 5

From Alzheimer's to autism, nuclear neurology could launch revolution in diagnosing and treating brain diseases

by Ellen Goldbaum,University at BuffaloImage of glucose metabolism PET overlaid on CT in an Alzheimer's patient with mild dementia. Green arrow points to regional hypometabolism in the media

Updated on:May 13,2024 5

Medical nutrition-drink may affect development of early Alzheimer's

by Karolinska InstitutetIn a new study, an international research team shows that a medical nutrition-drink, consisting of, among other things, essential fatty acids and vitamins, may have an imp

Updated on: March 07,2024 20

Medical nutrition-drink may affect development of early Alzheimer's

by Karolinska InstitutetIn a new study, an international research team shows that a medical nutrition-drink, consisting of, among other things, essential fatty acids and vitamins, may have an imp

Updated on:March 07,2024 20